Clinical trials
Recruiting Major Depressive Disorder trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Cybin IRL Limited | 1 |
| Neurocrine Biosciences | 1 |
| Royal North Shore Hospital | 1 |
| Senseye, Inc. | 1 |
| University of California, San Diego | 1 |
| atai Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 8 |
| Depressive Disorder | 4 |
| Mood Disorders | 3 |
| Depressive Disorder, Treatment-Resistant | 2 |
| Anxiety Disorders | 1 |
| Combat Disorders | 1 |
| Mental Disorders | 1 |
| Stress Disorders, Post-Traumatic | 1 |
| Wounds and Injuries | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.